Biphenyl Compound Structure Optimization for Therapeutic Activity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biphenyl compounds, despite their wide range of biological activities, require further study on their exact mechanism of action and structure-activity relationships for effective use in treating inflammation-related diseases, tumors, autoimmune diseases, neurodegenerative diseases, and metabolic diseases.

Innovation Solution

A biphenyl compound with a specific structure represented by Formula I, along with its isomers, pharmaceutically acceptable salts, prodrugs, and co-crystals, is synthesized and used to develop a pharmaceutical composition for preventing and treating tumors, autoimmune diseases, inflammatory diseases, neurodegenerative diseases, and metabolic diseases, through methods involving nucleophilic addition, iodination, coupling reactions, and hydrolysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If biphenyl compounds are used for treating inflammation-related diseases and tumors, then therapeutic activity is improved, but the exact mechanism of action and structure-activity relationships remain unclear

Engineering Contradiction:
Improvetherapeutic activityVSAvoidmechanism of action
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent applies parameter changes by systematically modifying the chemical structure of biphenyl compounds through varying substituents (R1, R2, R3, R4, R5, R6) and their positions on the phenyl rings. This structure optimization approach allows researchers to correlate specific structural parameters with therapeutic activity, thereby clarifying structure-activity relationships while maintaining improved therapeutic effects for treating inflammation-related diseases and tumors

Inventive Principle:
Principle #35Parameter changes

2Reliability

If natural products are modified to discover precursors with stronger activity, then therapeutic activity is improved, but complexity of structure optimization increases

Engineering Contradiction:
Improvetherapeutic activityVSAvoidstructure optimization
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the biphenyl compound structure into distinct modular components: two phenyl rings with independently variable substituents (R1-R6) at specific positions. This modular approach allows systematic optimization of each segment's properties to enhance therapeutic activity while managing the complexity of structure-activity relationship studies

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs parameter changes by systematically varying substituent types (hydrogen, halogen, hydroxy, alkyl, alkoxy, amino, nitro, cyano, carboxyl groups) and their positions on the phenyl rings. This methodical parameter optimization enables discovery of precursors with stronger therapeutic activity while maintaining organized structure optimization processes

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP4527828A1Biphenyl compound, pharmaceutical composition, method for preparing same, and use thereof
Publication Date: 2025.03.26 LONGIVITRON (SUZHOU) BIOTECHNOLOGY CO LTD
  • EP4527828A1 patent drawingFigure 1~2
  • EP4527828A1 patent drawingFigure 3~4
  • EP4527828A1 patent drawingFigure 5~6

AI summary

Provided are a biphenyl compound, a pharmaceutical composition, a method for preparing same, and use thereof. The biphenyl compound has a structure represented by formula I. The provided biphenyl compound can have relatively good binding to multiple target proteins, has relatively good bioavailability, and can be used for preparing drugs for preventing or treating tumors, autoimmune diseases, inflammatory diseases, and neurodegenerative diseases or anti-aging drugs.